References
- Nb W, Ra A, Jp B, et al. Osteoporosis in men: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:1802–1822.
- de Paiva Gonçalves V, Cabrera-Ortega AA, Carvalho JS, et al. Physiologic testosterone replacement on male aged rats with orchiectomy induced osteoporosis in advanced stage: a tomographic and biomechanics pilot study. Aging Male. 2021;24(1):139–147.
- Mendoza FA, Le Roux M, Ahmed I. Primary osteoporosis in men: an unmet medical need. Fertil Steril. 2019;112(5):791–798.
- Groti Antonič K. Impact of testosterone therapy on bone turnover markers in obese males with type 2 diabetes and functional hypogonadism. Aging Male. 2022;25(1):269–277.
- Morgentaler A, Khera M, Maggi M, et al. Commentary: who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014;11:1636–1645.
- Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol. 2009;55:121–130.
- Buvat J, Maggi M, Gooren L, et al. Endocrine aspects of male sexual dysfunction. J Sex Med. 2010;7:1627–1656.
- Paduch DA, Brannigan RE, Fuchs EF, et al. The laboratory diagnosis of testosterone deficiency. Urology 2014;83:980–988.
- Morgentaler A, Zitzmann M, Traish AM, et al. Fundamental concepts regarding testosterone deficiency and treatment: International expert consensus resolutions. Mayo Clin Proc. 2016;91(7):881–896.
- Park H, Ahn S, Moon D, et al. Evolution of guidelines for testosterone replacement therapy. JCM. 2019;8(3):410.
- Seftel AD, Kathrins M, Niederberger C. Critical update of the 2010 endocrine society clinical practice guidelines for male hypogonadism: a systematic analysis. Mayo Clin Proc. 2015;90:1104–1115.
- Zhang Z, Kang D, Li H. The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis. BMC Endocr Disord. 2020;20(1):12.
- Isidori AM, Giannetta E, Greco EA, et al. Effects of testosterone on body composition, bone metabolism, and serum lip profile in male-age men: meta analysis. Clin Endocrinol (Oxf). 2005;63(3):280–293.
- Shigehara K, Izumi K, Kadono Y, et al. Testoerone and bone health for me: a narrative review. JCM. 2021;10(3):530.
- Yarrow JF, Conover CF, Purandare AV, et al. Supraphysiological testosterone enanthate administration prevents bone loss and augments bone strength in gonadectomized male and female rats. Am J Physiol Endocrinol Metab. 2008;295(5):E1213–E1222.
- Alves JV, Costa R D, Pereira CA, et al. Supraphysiological levels of testosterone induce vascular dysfunction via activation of the NLRP3 inflammasome. Front Immunol. 2020;11:1647.
- Rabijewski M, Papierska L, Piątkiewicz P. An association between bone mineral density anabolic hormone in middle age and elderly men with pre diabetes. Aging Male. 2017;20(3):205–213.
- Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on skeletal muscle. J Clin Endocrinol Metab. 2005;90:678–688.
- Lips P, van Schoor NM. The effect of vitamin d on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011;25(4):585–591.
- Shigehara K, Konaka H, Koh E, et al. Effects of testosterone replacement therapy on hypogonadal men with osteopenia or osteoporosis: a subanalysis of a prospective randomized controlled study in Japan (EARTH study). Aging Male. 2017;20(3):139–145.
- Donovitz GS. Low complication rates of testosterone and estradiol implants for androgen and estrogen replacement therapy in over 1 million procedures. Ther Adv Endocrinol. 2021;12:204201882110152.